Myriad Genetics Inc
MYGN
|
|
| |
|
| Trading Volume | 38,492 |
|
|
28.31 - 13.91 |
| Market Cap Full | $ 2.3B |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | -66.3% | -0.4% | 11.3% | 60.1% |
| Q2 | - | 166% | 13.3% | -0.2% |
| Q3 | - | 166% | 1.2% | -30.8% |
| Q4 | - | 166% | -22.3% | 23.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| -0.4 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 11.8 | -2.2 | 1.8 | -13.1 | 22.9 | 6.8 | 15.1 | 1.2 | - | - | - | -15.5 |
| 2023 | |||||||||||
| 35.9 | -4.1 | 22.8 | -8.4 | 3.6 | 5.1 | -3.6 | -20.1 | -10.1 | -2.9 | 22.5 | 0.3 |
| 2022 | |||||||||||
| -6.1 | -5.1 | 2.4 | -18.7 | -6.2 | -5.6 | 45.2 | -15.1 | -14.9 | 8.7 | -2.3 | -28.4 |
| 2021 | |||||||||||
| 40 | 11.9 | -2 | - | -4.6 | 6 | 3.4 | 13.1 | -9.8 | -4.7 | -16 | 6.7 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.7 | -0.3 | -0.5 |
| Q2 | -1.4 | -0.2 | -0.1 |
| Q3 | -0.8 | -0.4 | 0.3 |
| Q4 | 0 | -0.5 | -0.1 |
| A | -2.84 | -1.4 | -0.4 |